RANI - צמיחת מכירות משנה לשנה (TTM) ranitherapeutics.com

This TTM annual sales growth chart illustrates revenue dynamics, where the value of 450.00 characterizes this level. Rani Therapeutics (RANI) minimizes external orders by assembling capsules at its own facilities. The innovative "robotic pill" and patents provide the company with a competitive edge over industry behemoths. However, a lack of profitability and clinical costs are leading to the planned depletion of existing cash reserves.
Rani Therapeutics Holdings, Inc. - פילוחים אנליטיים ומדדי מפתח (RANI)

Establishing a long-term position requires assessing the balance between expansion rates and asset valuation. For Rani Therapeutics (RANI), revenue is primarily generated through milestone payments from pharmaceutical partners for the RaniPill technology. The 12-month trailing sales growth rate converts quarterly reporting into a continuous trend of current momentum. This metric measures the actual speed of business scaling by smoothing out information gaps. Stable growth confirms the commercial demand for the robotic protein delivery platform.